Xconomy’s Digital Events →
December 3, 2020 · New York
NPS Pharmaceuticals CEO Francois Nader is an Xconomist.
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Sponsored · Whitepaper
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.